\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ reveals\\ a\\ hard\\ subcutaneous\\ mass\\ located\\ in\\ the\\ right\\ breast\\ at\\ 1200\\;\\ approximately\\ 5cm\\ from\\ the\\ nipple\\.\ \(0\)\
\-\ treatment\\ is\\ currently\\ pending\\ along\\ with\\ estrogen\\/progesterone\\ receptor\\ assays\\ and\\ her\\-2\\/neu\\ studies\\.\ \(0\)\
\-\ mammogram\\:\\ \\ spiculated\\,\\ ill\\-defined\\ density\\,\\ located\\ midline\\ craniocaudal\\ view\\ and\\ superior\\ to\\ nipple\\ in\\ mediolateral\\ view\\.\\ \\ birads\\ v\\.\\ \\ the\\ images\\ were\\ compared\\ with\\ prior\\ studies\\ from\\ 2001\\ and\\ 2002\\ showing\\ a\\ density\\ increased\\ in\\ size\\ and\\ irregularity\\.\\ \\ past\\ workup\\ of\\ following\\ the\\ 2002\\ mammogram\\ included\\ spot\\ compression\\ vies\\ and\\ ultrasound\\;\\ however\\,\\ had\\ the\\ 2001\\ films\\ been\\ present\\ at\\ that\\ time\\,\\ biopsy\\ of\\ the\\ new\\ assymetric\\ density\\ would\\ have\\ been\\ more\\ appropriate\\.\ \(0\)\
\-\ ultrasound\\ exam\\ of\\ this\\ region\\ demonstrates\\ a\\ 2\\.8\\ cm\\ heterogeneously\\ hypoechoic\\ mass\\ with\\ irregular\\ margins\\ and\\ posterior\\ acoustic\\ shadowing\\.\ \(0\)\
\-\ invasive\\ ductal\\ carcinoma\ \(7\)\
\-\ differential\\ diagnosis\\ for\\ these\\ findings\\ in\\ this\\ case\\:\ \(0\)\
\-\ 1\\.\\	invasive\\ ductal\\ carcinoma\ \(0\)\
\-\ 2\\.\\	invasive\\ lobular\\ carcinoma\ \(0\)\
\-\ 3\\.\\	phylloides\\ tumor\ \(0\)\
\-\ 4\\.\\	metastasis\ \(0\)\
\-\ 5\\.\\	benign\\ fibrocystic\\ change\ \(0\)\
\-\ history\\:\\ \\ a\\ 56\\ year\\ old\\ post\\ menopausal\\ female\\ presents\\ to\\ mgmc\\ mammography\\ with\\ the\\ complaint\\ of\\ a\\ palpable\\ breast\\ mass\\ in\\ her\\ right\\ breast\\.\\ \\ the\\ mass\\ has\\ been\\ palpable\\ by\\ the\\ patient\\ for\\ 3\\-4\\ weeks\\.\ \(0\)\
\-\ last\\ mammogram\\:\\ 29\\ august\\ 2002\\.\\ \\ patient\\ underwent\\ spot\\ compression\\ views\\ for\\ an\\ asymmetric\\ density\\ as\\ well\\ as\\ ultrasound\\ at\\ that\\ time\\;\\ no\\ evidence\\ of\\ malignancy\\ was\\ found\\ and\\ routine\\ annual\\ follow\\-up\\ was\\ recommended\\.\ \(0\)\
\-\ family\\ history\\ is\\ significant\\ for\\ breast\\ cancer\\ in\\:\\ sister\\ 39\\ years\\,\\ mother\\ 70\\ years\\,\\ paternal\\ aunt\\ 60\\ years\\.\ \(0\)\
\-\ the\\ most\\ common\\ type\\ of\\ breast\\ cancer\\ is\\ invasive\\ ductal\\ \\(70\\-80\\%\\)\\.\\ \\ invasive\\ ductal\\ carcinoma\\ typically\\ invades\\ in\\ a\\ fashion\\ creating\\ irregular\\,\\ stellate\\ shapes\\.\\ \\ a\\ fibrous\\ response\\ is\\ induced\\ by\\ the\\ malignant\\ cells\\;\\ leading\\ to\\ a\\ palpable\\ mass\\,\\ density\\ on\\ mammography\\ and\\ hypoechoic\\,\\ shadowing\\ nature\\ on\\ sonogram\\.\\ \\ \ \(0\)\
\-\ though\\ only\\ 15\\%\\ of\\ all\\ breast\\ cancers\\ have\\ a\\ genetic\\ factor\\ involved\\,\\ this\\ patient\\ has\\ a\\ history\\ of\\ two\\ first\\ degree\\ relatives\\ with\\ breast\\ cancer\\.\\ \\ annual\\ mammograms\\ would\\ likely\\ have\\ lead\\ to\\ an\\ earlier\\ diagnosis\\ and\\ treatment\\.\ \(0\)\
\-\ breast\\ imaging\\ reporting\\ and\\ data\\ system\ \(0\)\
\-\ birads\\:\ \(0\)\
\-\ 1\\ negative\\:\\ no\\ findings\\,\\ routine\\ follow\\ up\ \(1\)\
\-\ 2\\ benign\\:\\ all\\ findings\\ suggest\\ benign\\ pathology\\,\\ routine\\ follow\\-up\ \(1\)\
\-\ 3\\ probably\\ benign\\:\\ most\\ findings\\ suggest\\ benign\\ path\\,\\ less\\ than\\ 2\\ percent\\ probability\\ of\\ malignancy\\.\\ \\ short\\ interval\\ follow\\ up\\ is\\ recommended\ \(0\)\
\-\ 4\\ suspicious\\ findings\\:\\ consider\\ biopsy\\,\\ 2\\-75\\%\\ of\\ lesions\\ are\\ malignant\ \(1\)\
\-\ 5\\ highly\\ suggestive\\ of\\ malignancy\\:\\ \\ recommend\\ appropriate\\ management\\;\\ \\>75\\%\\ of\\ lesions\\ of\\ this\\ category\\ are\\ malignant\ \(1\)\
\-\ 0\\ incomplete\\.\\ \\ further\\ imaging\\ is\\ needed\\ to\\ evaluate\\ the\\ tissue\\.\ \(0\)\
\-\ many\\ critics\\ of\\ the\\ birads\\ system\\ suggest\\ only\\ 4\\ classifications\\ are\\ needed\\:\\ biopsy\\ recommended\\,\\ short\\ interval\\ followup\\ necessary\\,\\ benign\\ findings\\,\\ and\\ incomplete\\ study\\.\\ \ \(0\)\
\-\ commonly\\ used\\ indications\\ of\\ malignancy\\ on\\ sonogram\\:\\ \\ \ \(0\)\
\-\ 1\\.\\	spiculation\\,\\ \ \(1\)\
\-\ 2\\.\\	angular\\ margins\\,\\ \ \(1\)\
\-\ 3\\.\\	marked\\ hypoechogenecity\\,\\ \ \(1\)\
\-\ 4\\.\\	shadowing\\,\\ \ \(1\)\
\-\ 5\\.\\	duct\\ extension\\,\\ \ \(1\)\
\-\ 6\\.\\	branch\\ pattern\\,\\ \ \(1\)\
\-\ 7\\.\\	microlobulation\\.\\ \ \(1\)\
\-\ 8\\.\\	architectural\\ distortion\\,\\ \ \(0\)\
\-\ 9\\.\\	taller\\ than\\ wide\\,\\ \ \(1\)\
\-\ 10\\.\\	skin\\ thickening\\,\\ \ \(1\)\
\-\ 11\\.\\	marked\\ vascularity\\ \ \(1\)\
\-\ references\\:\ \(0\)\
\-\ crystal\\,\\ pavel\\,\\ selwyn\\ d\\.\\ strano\\,\\ semyon\\ shcharynski\\ and\\ michael\\ j\\.\\ koretz\\.\\ \\ using\\ sonography\\ to\\ screen\\ women\\ with\\ mammographically\\ dense\\ breasts\\.\\ ajr\\ \\ \\ \\ \\ \\ \\ \\ \\ 2003\\;\\ 181\\:177\\-182\\.\ \(0\)\
\-\ taplin\\,\\ stephen\\ h\\.\\,\\ carolyn\\ m\\.\\ rutter\\,\\ charles\\ finder\\,\\ margaret\\ t\\.\\ mandelson\\,\\ florence\\ houn\\ and\\ emily\\ white\\.\\ \\ screening\\ mammography\\ clinical\\ image\\ quality\\ and\\ the\ \(0\)\
\-\ risk\\ of\\ interval\\ breast\\ cancer\\.\\ \\ ajr\\ 2002\\;\\ 178\\:797\\-803\\.\ \(0\)\
\-\ esserman\\,\\ laura\\ j\\.\\ md\\,\\ mba\\.\\ \\ and\\ paul\\ c\\ stomper\\,\\ m\\.d\\.\\ diagnostic\\ evaluation\\ and\\ initial\\ staging\\ work\\-up\\ of\\ women\\ with\\ suspected\\ breast\\ cancer\\.\\ \\ \\ up\\-to\\-date\\.\\ \\ \\ \\ \\ 10\\ feb\\ 2005\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.049803443030498454\ \(0\)\
\-\ invasive\\:\\ 0\\.03391571759018529\ \(0\)\
\-\ birads\\:\\ 0\\.032557385189152535\ \(0\)\
\-\ benign\\:\\ 0\\.027953084047708073\ \(0\)\
\-\ ductal\\:\\ 0\\.025453565125968105\ \(0\)\
\-\ \\:\\:\\ 0\\.024998179184627663\ \(0\)\
\-\ mammography\\:\\ 0\\.023532563138656114\ \(0\)\
\-\ \\;\\:\\ 0\\.02239802262111873\ \(0\)\
\-\ density\\:\\ 0\\.022208778490205045\ \(0\)\
\-\ cancer\\:\\ 0\\.02218929908660952\ \(0\)\
\-\ 2002\\:\\ 0\\.022143998566706\ \(0\)\
\-\ shadowing\\:\\ 0\\.021511148364694043\ \(0\)\
\-\ mammogram\\:\\ 0\\.02113179903922705\ \(0\)\
\-\ malignancy\\:\\ 0\\.020866285483737857\ \(0\)\
\-\ interval\\:\\ 0\\.01986040573783046\ \(0\)\
\-\ sonogram\\:\\ 0\\.0183879499223144\ \(0\)\
\-\ suggest\\:\\ 0\\.017248192850202224\ \(0\)\
\-\ findings\\:\\ 0\\.017240160528814785\ \(0\)\
\-\ ajr\\:\\ 0\\.01721397344069518\ \(0\)\
\-\ recommended\\:\\ 0\\.016789188935558065\ \(0\)\
\-\ routine\\:\\ 0\\.016239083858530793\ \(0\)\
\-\ nipple\\:\\ 0\\.016043756100104674\ \(0\)\
\-\ j\\.\\:\\ 0\\.01589677342827247\ \(0\)\
\-\ \\,\\:\\ 0\\.015823495140820907\ \(0\)\
\-\ carcinoma\\:\\ 0\\.015304440252864876\ \(0\)\
\-\ malignant\\:\\ 0\\.014638249651086736\ \(0\)\
\-\ incomplete\\:\\ 0\\.01456816999865887\ \(0\)\
\-\ spot\\:\\ 0\\.014521360880854317\ \(0\)\
\-\ biopsy\\:\\ 0\\.014368214415340098\ \(0\)\
\-\ palpable\\:\\ 0\\.014353654230330762\ \(0\)\
\-\ 2001\\:\\ 0\\.014340765576462695\ \(0\)\
\-\ 1200\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ estrogen\\/progesterone\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ assays\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ her\\-2\\/neu\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ vies\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ mgmc\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ 2\\-75\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ critics\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ hypoechogenecity\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ microlobulation\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ pavel\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ selwyn\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ strano\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ semyon\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ shcharynski\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ koretz\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ 181\\:177\\-182\\.\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ taplin\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ carolyn\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ rutter\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ finder\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ margaret\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ mandelson\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ florence\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ houn\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ emily\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ 178\\:797\\-803\\.\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ mba\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ stomper\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ up\\-to\\-date\\:\\ 0\\.013926569390152447\ \(0\)\
\-\ annual\\:\\ 0\\.013532129323264587\ \(0\)\
\-\ women\\:\\ 0\\.013118734059571664\ \(0\)\
\-\ esserman\\:\\ 0\\.012831550147561694\ \(0\)\
\-\ laura\\:\\ 0\\.012831550147561694\ \(0\)\
\-\ appropriate\\:\\ 0\\.012726782562984052\ \(0\)\
\-\ short\\:\\ 0\\.012726782562984052\ \(0\)\
\-\ \\%\\:\\ 0\\.012596025487178563\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.01230817534956832\ \(0\)\
\-\ margins\\:\\ 0\\.012262383857301126\ \(0\)\
\-\ phylloides\\:\\ 0\\.012191004953078023\ \(0\)\
\-\ taller\\:\\ 0\\.012191004953078023\ \(0\)\
\-\ ultrasound\\:\\ 0\\.012014798981072529\ \(0\)\
\-\ years\\:\\ 0\\.011892147568807975\ \(0\)\
\-\ needed\\:\\ 0\\.01175914130540201\ \(0\)\
\-\ menopausal\\:\\ 0\\.011736530904970944\ \(0\)\
\-\ mammographically\\:\\ 0\\.011736530904970944\ \(0\)\
\-\ paul\\:\\ 0\\.011736530904970944\ \(0\)\
\-\ 5\\.\\:\\ 0\\.01164492799065853\ \(0\)\
\-\ relatives\\:\\ 0\\.0113840134463387\ \(0\)\
\-\ spiculation\\:\\ 0\\.0113840134463387\ \(0\)\
\-\ michael\\:\\ 0\\.0113840134463387\ \(0\)\
\-\ located\\:\\ 0\\.011112799549505408\ \(0\)\
\-\ mediolateral\\:\\ 0\\.01109598571048727\ \(0\)\
\-\ paternal\\:\\ 0\\.01109598571048727\ \(0\)\
\-\ 70\\-80\\:\\ 0\\.01109598571048727\ \(0\)\
\-\ shapes\\:\\ 0\\.01109598571048727\ \(0\)\
\-\ stephen\\:\\ 0\\.01109598571048727\ \(0\)\
\-\ been\\:\\ 0\\.011017985258123182\ \(0\)\
\-\ invades\\:\\ 0\\.010852461729717511\ \(0\)\
\-\ irregular\\:\\ 0\\.010768867780430898\ \(0\)\
\-\ classifications\\:\\ 0\\.010641511662380193\ \(0\)\
\-\ angular\\:\\ 0\\.010641511662380193\ \(0\)\
\-\ 4\\.\\:\\ 0\\.010630268468880877\ \(0\)\
\-\ system\\:\\ 0\\.010630268468880877\ \(0\)\
\-\ marked\\:\\ 0\\.010536744077802548\ \(0\)\
\-\ reporting\\:\\ 0\\.010455440516003599\ \(0\)\
\-\ assymetric\\:\\ 0\\.01028899420374795\ \(0\)\
\-\ stellate\\:\\ 0\\.010138425199317737\ \(0\)\
\-\ m\\.d\\:\\ 0\\.010138425199317737\ \(0\)\
\-\ view\\:\\ 0\\.010129689190462997\ \(0\)\
\-\ compression\\:\\ 0\\.010106626623380495\ \(0\)\
\-\ studies\\:\\ 0\\.01008373117781725\ \(0\)\
\-\ receptor\\:\\ 0\\.01000096646789652\ \(0\)\
\-\ v\\.\\:\\ 0\\.01000096646789652\ \(0\)\
\-\ fibrocystic\\:\\ 0\\.01000096646789652\ \(0\)\
\-\ aunt\\:\\ 0\\.009874516692740854\ \(0\)\
\-\ 5cm\\:\\ 0\\.00975744248712676\ \(0\)\
\-\ 2002\\.\\:\\ 0\\.00975744248712676\ \(0\)\
\-\ would\\:\\ 0\\.00960811020038575\ \(0\)\
\-\ probability\\:\\ 0\\.009450718925608661\ \(0\)\
\-\ mass\\:\\ 0\\.009387527701007618\ \(0\)\
\-\ sister\\:\\ 0\\.009360421273412849\ \(0\)\
\-\ t\\.\\:\\ 0\\.009360421273412849\ \(0\)\
\-\ 3\\.\\:\\ 0\\.00923814916948097\ \(0\)\
\-\ 2\\.8\\:\\ 0\\.0091939749611572\ \(0\)\
\-\ creating\\:\\ 0\\.0091939749611572\ \(0\)\
\-\ crystal\\:\\ 0\\.0091939749611572\ \(0\)\
\-\ quality\\:\\ 0\\.009116897292643087\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.009043405956726987\ \(0\)\
\-\ recommend\\:\\ 0\\.00897318200321856\ \(0\)\
\-\ architectural\\:\\ 0\\.00897318200321856\ \(0\)\
\-\ feb\\:\\ 0\\.00897318200321856\ \(0\)\
\-\ fashion\\:\\ 0\\.00890594722530577\ \(0\)\
\-\ indications\\:\\ 0\\.00890594722530577\ \(0\)\
\-\ category\\:\\ 0\\.008841457502524956\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.008783687176751159\ \(0\)\
\-\ have\\:\\ 0\\.008769848712630767\ \(0\)\
\-\ h\\.\\:\\ 0\\.00866242324453601\ \(0\)\
\-\ 2\\.\\:\\ 0\\.008585921459084545\ \(0\)\
\-\ follow\\:\\ 0\\.008578829295249397\ \(0\)\
\-\ mammograms\\:\\ 0\\.008553429766673526\ \(0\)\
\-\ path\\:\\ 0\\.008553429766673526\ \(0\)\
\-\ 1\\.\\:\\ 0\\.008433457081509008\ \(0\)\
\-\ 11\\.\\:\\ 0\\.008402860762243313\ \(0\)\
\-\ 10\\.\\:\\ 0\\.008355699683017909\ \(0\)\
\-\ breasts\\:\\ 0\\.008355699683017909\ \(0\)\
\-\ august\\:\\ 0\\.008309905785903767\ \(0\)\
\-\ spiculated\\:\\ 0\\.008222117711409595\ \(0\)\
\-\ cancers\\:\\ 0\\.008138952255666432\ \(0\)\
\-\ only\\:\\ 0\\.008118204292211486\ \(0\)\
\-\ induced\\:\\ 0\\.008098955718566447\ \(0\)\
\-\ 0\\:\\ 0\\.008098955718566447\ \(0\)\
\-\ distortion\\:\\ 0\\.008021878050052337\ \(0\)\
\-\ d\\.\\:\\ 0\\.008021878050052337\ \(0\)\
\-\ sonography\\:\\ 0\\.008021878050052337\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.007948386714136235\ \(0\)\
\-\ 3\\-4\\:\\ 0\\.007912884572189856\ \(0\)\
\-\ 9\\.\\:\\ 0\\.007912884572189856\ \(0\)\
\-\ m\\.\\:\\ 0\\.007912884572189856\ \(0\)\
\-\ screen\\:\\ 0\\.007844187712885371\ \(0\)\
\-\ staging\\:\\ 0\\.007778354069282577\ \(0\)\
\-\ all\\:\\ 0\\.007636409129324773\ \(0\)\
\-\ time\\:\\ 0\\.007625912250361177\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.007624856836338426\ \(0\)\
\-\ lobular\\:\\ 0\\.007624856836338426\ \(0\)\
\-\ charles\\:\\ 0\\.007624856836338426\ \(0\)\
\-\ work\\-up\\:\\ 0\\.007624856836338426\ \(0\)\
\-\ acoustic\\:\\ 0\\.007567404001945259\ \(0\)\
\-\ 8\\.\\:\\ 0\\.0075394425847266165\ \(0\)\
\-\ 4\\:\\ 0\\.007522818025842165\ \(0\)\
\-\ vascularity\\:\\ 0\\.007458410524082777\ \(0\)\
\-\ hard\\:\\ 0\\.007432297882769647\ \(0\)\
\-\ genetic\\:\\ 0\\.007381332855568666\ \(0\)\
\-\ percent\\:\\ 0\\.007356453934607939\ \(0\)\
\-\ consider\\:\\ 0\\.00733196074892711\ \(0\)\
\-\ data\\:\\ 0\\.007307841519652563\ \(0\)\
\-\ branch\\:\\ 0\\.007307841519652563\ \(0\)\
\-\ 2005\\:\\ 0\\.007284084999329435\ \(0\)\
\-\ up\\:\\ 0\\.0072601805720512586\ \(0\)\
\-\ wide\\:\\ 0\\.007237617566144137\ \(0\)\
\-\ lesions\\:\\ 0\\.007227679324941383\ \(0\)\
\-\ irregularity\\:\\ 0\\.0072148865433130155\ \(0\)\
\-\ probably\\:\\ 0\\.007192477957227777\ \(0\)\
\-\ 7\\.\\:\\ 0\\.007192477957227777\ \(0\)\
\-\ 56\\:\\ 0\\.007105893065450534\ \(0\)\
\-\ than\\:\\ 0\\.007074403964986647\ \(0\)\
\-\ 29\\:\\ 0\\.007043933013075682\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.007023808169825398\ \(0\)\
\-\ workup\\:\\ 0\\.0069457785405527646\ \(0\)\
\-\ 75\\:\\ 0\\.006908162981794916\ \(0\)\
\-\ factor\\:\\ 0\\.0068896858257709165\ \(0\)\
\-\ 2003\\:\\ 0\\.006783143518037058\ \(0\)\
\-\ response\\:\\ 0\\.006766064661632294\ \(0\)\
\-\ earlier\\:\\ 0\\.0066672963251688915\ \(0\)\
\-\ md\\:\\ 0\\.0066672963251688915\ \(0\)\
\-\ asymmetric\\:\\ 0\\.006559367029785832\ \(0\)\
\-\ 6\\.\\:\\ 0\\.006559367029785832\ \(0\)\
\-\ suspicious\\:\\ 0\\.0065008500129132415\ \(0\)\
\-\ highly\\:\\ 0\\.0065008500129132415\ \(0\)\
\-\ 70\\:\\ 0\\.006486553274335173\ \(0\)\
\-\ lead\\:\\ 0\\.0064723847593545075\ \(0\)\
\-\ leading\\:\\ 0\\.006458342188395193\ \(0\)\
\-\ followup\\:\\ 0\\.006444423342135865\ \(0\)\
\-\ c\\:\\ 0\\.0064169482351660884\ \(0\)\
\-\ nature\\:\\ 0\\.006389942811217746\ \(0\)\
\-\ dense\\:\\ 0\\.006376611265173726\ \(0\)\
\-\ imaging\\:\\ 0\\.006325667691802852\ \(0\)\
\-\ degree\\:\\ 0\\.006324382414840569\ \(0\)\
\-\ 39\\:\\ 0\\.00627382517773761\ \(0\)\
\-\ a\\:\\ 0\\.006265399712774111\ \(0\)\
\-\ though\\:\\ 0\\.00626143469201719\ \(0\)\
\-\ complaint\\:\\ 0\\.006236941506336359\ \(0\)\
\-\ most\\:\\ 0\\.006233286387766433\ \(0\)\
\-\ included\\:\\ 0\\.006224835862188542\ \(0\)\
\-\ showing\\:\\ 0\\.0062128222770618125\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006199745120949194\ \(0\)\
\-\ duct\\:\\ 0\\.0061890657567386835\ \(0\)\
\-\ mother\\:\\ 0\\.006165661197836408\ \(0\)\
\-\ this\\:\\ 0\\.0060735368929803035\ \(0\)\
\-\ necessary\\:\\ 0\\.005979590051459815\ \(0\)\
\-\ exam\\:\\ 0\\.005931228878197593\ \(0\)\
\-\ 60\\:\\ 0\\.005889292399264004\ \(0\)\
\-\ using\\:\\ 0\\.00586030481842957\ \(0\)\
\-\ pending\\:\\ 0\\.0058412711082934336\ \(0\)\
\-\ 2\\:\\ 0\\.005813916260696828\ \(0\)\
\-\ suspected\\:\\ 0\\.005813143739204165\ \(0\)\
\-\ last\\:\\ 0\\.0057673498420900225\ \(0\)\
\-\ suggestive\\:\\ 0\\.0057673498420900225\ \(0\)\
\-\ screening\\:\\ 0\\.005758348228954734\ \(0\)\
\-\ compared\\:\\ 0\\.0057140938273312365\ \(0\)\
\-\ involved\\:\\ 0\\.005662574734773952\ \(0\)\
\-\ references\\:\\ 0\\.005612682835800336\ \(0\)\
\-\ history\\:\\ 0\\.0055934338279956565\ \(0\)\
\-\ films\\:\\ 0\\.005572277082578141\ \(0\)\
\-\ views\\:\\ 0\\.00556431848221486\ \(0\)\
\-\ many\\:\\ 0\\.005548520562255012\ \(0\)\
\-\ family\\:\\ 0\\.005532879059912655\ \(0\)\
\-\ pathology\\:\\ 0\\.005525116003352736\ \(0\)\
\-\ are\\:\\ 0\\.0055207292536947955\ \(0\)\
\-\ at\\:\\ 0\\.0054870291603394935\ \(0\)\
\-\ treatment\\:\\ 0\\.005464824516906436\ \(0\)\
\-\ fibrous\\:\\ 0\\.005456913520153353\ \(0\)\
\-\ evaluate\\:\\ 0\\.005456913520153353\ \(0\)\
\-\ cells\\:\\ 0\\.005413027952843597\ \(0\)\
\-\ 15\\:\\ 0\\.005384433890215449\ \(0\)\
\-\ currently\\:\\ 0\\.005349404099545114\ \(0\)\
\-\ diagnostic\\:\\ 0\\.005349404099545114\ \(0\)\
\-\ is\\:\\ 0\\.005329770411229627\ \(0\)\
\-\ reveals\\:\\ 0\\.005281592022582975\ \(0\)\
\-\ change\\:\\ 0\\.005261803302489484\ \(0\)\
\-\ midline\\:\\ 0\\.005222954324389449\ \(0\)\
\-\ skin\\:\\ 0\\.005185037812383851\ \(0\)\
\-\ used\\:\\ 0\\.005178805935146859\ \(0\)\
\-\ pattern\\:\\ 0\\.005160256459828243\ \(0\)\
\-\ management\\:\\ 0\\.005094046514147932\ \(0\)\
\-\ commonly\\:\\ 0\\.005094046514147932\ \(0\)\
\-\ has\\:\\ 0\\.005070142086869757\ \(0\)\
\-\ metastasis\\:\\ 0\\.005053313311690248\ \(0\)\
\-\ risk\\:\\ 0\\.004889741938955903\ \(0\)\
\-\ extension\\:\\ 0\\.004818842529512881\ \(0\)\
\-\ typically\\:\\ 0\\.004765285575838819\ \(0\)\
\-\ new\\:\\ 0\\.004704246408847644\ \(0\)\
\-\ that\\:\\ 0\\.004663446219775113\ \(0\)\
\-\ in\\:\\ 0\\.004660000965216089\ \(0\)\
\-\ underwent\\:\\ 0\\.004632221225084074\ \(0\)\
\-\ for\\:\\ 0\\.004607318474835483\ \(0\)\
\-\ thickening\\:\\ 0\\.004576026176450793\ \(0\)\
\-\ less\\:\\ 0\\.004571785156907871\ \(0\)\
\-\ type\\:\\ 0\\.004550749175903492\ \(0\)\
\-\ 10\\:\\ 0\\.004550749175903492\ \(0\)\
\-\ and\\:\\ 0\\.004549990666217212\ \(0\)\
\-\ first\\:\\ 0\\.004529989628413668\ \(0\)\
\-\ size\\:\\ 0\\.004525870254942767\ \(0\)\
\-\ by\\:\\ 0\\.004495642664280805\ \(0\)\
\-\ \\>\\:\\ 0\\.004485256737233119\ \(0\)\
\-\ white\\:\\ 0\\.00447725783998739\ \(0\)\
\-\ initial\\:\\ 0\\.004473273528087374\ \(0\)\
\-\ along\\:\\ 0\\.0044613805321619526\ \(0\)\
\-\ study\\:\\ 0\\.00444175569804101\ \(0\)\
\-\ superior\\:\\ 0\\.00431081152773174\ \(0\)\
\-\ further\\:\\ 0\\.004292960729542272\ \(0\)\
\-\ past\\:\\ 0\\.004289414647624699\ \(0\)\
\-\ differential\\:\\ 0\\.004285876507666556\ \(0\)\
\-\ found\\:\\ 0\\.004254384856954364\ \(0\)\
\-\ post\\:\\ 0\\.004250924222863023\ \(0\)\
\-\ image\\:\\ 0\\.004216728540754504\ \(0\)\
\-\ approximately\\:\\ 0\\.004176647435316877\ \(0\)\
\-\ clinical\\:\\ 0\\.00415372796218958\ \(0\)\
\-\ as\\:\\ 0\\.00408397316238271\ \(0\)\
\-\ patient\\:\\ 0\\.0040596773977080005\ \(0\)\
\-\ her\\:\\ 0\\.004059102146105743\ \(0\)\
\-\ to\\:\\ 0\\.004048038942587547\ \(0\)\
\-\ negative\\:\\ 0\\.004031785405015599\ \(0\)\
\-\ from\\:\\ 0\\.004001376660834794\ \(0\)\
\-\ 5\\:\\ 0\\.003949700509390463\ \(0\)\
\-\ evaluation\\:\\ 0\\.00392138830304393\ \(0\)\
\-\ two\\:\\ 0\\.003866242081541873\ \(0\)\
\-\ following\\:\\ 0\\.003831402459559476\ \(0\)\
\-\ weeks\\:\\ 0\\.003831402459559476\ \(0\)\
\-\ region\\:\\ 0\\.0038129561251805887\ \(0\)\
\-\ likely\\:\\ 0\\.0038077250646692835\ \(0\)\
\-\ however\\:\\ 0\\.003758875285303429\ \(0\)\
\-\ an\\:\\ 0\\.003733538275781137\ \(0\)\
\-\ significant\\:\\ 0\\.0036300902860256293\ \(0\)\
\-\ cm\\:\\ 0\\.003620783756424938\ \(0\)\
\-\ evidence\\:\\ 0\\.00353940376519254\ \(0\)\
\-\ common\\:\\ 0\\.0035328076018268516\ \(0\)\
\-\ these\\:\\ 0\\.0035131827677059085\ \(0\)\
\-\ prior\\:\\ 0\\.003466212910272296\ \(0\)\
\-\ on\\:\\ 0\\.0034307630917792802\ \(0\)\
\-\ more\\:\\ 0\\.003376265891488414\ \(0\)\
\-\ physical\\:\\ 0\\.003312014643888212\ \(0\)\
\-\ increased\\:\\ 0\\.0033025036047387925\ \(0\)\
\-\ 1\\:\\ 0\\.003212205952542981\ \(0\)\
\-\ tissue\\:\\ 0\\.0031997175173026754\ \(0\)\
\-\ 3\\:\\ 0\\.0031610987783673612\ \(0\)\
\-\ tumor\\:\\ 0\\.003147286416446779\ \(0\)\
\-\ of\\:\\ 0\\.003128854049866988\ \(0\)\
\-\ was\\:\\ 0\\.0031225198174208114\ \(0\)\
\-\ posterior\\:\\ 0\\.0031115932838901243\ \(0\)\
\-\ were\\:\\ 0\\.003065223280710776\ \(0\)\
\-\ the\\:\\ 0\\.003057646107189196\ \(0\)\
\-\ well\\:\\ 0\\.003053840368038943\ \(0\)\
\-\ present\\:\\ 0\\.003048986973035831\ \(0\)\
\-\ case\\:\\ 0\\.002953403527436447\ \(0\)\
\-\ demonstrates\\:\\ 0\\.002948848659799662\ \(0\)\
\-\ had\\:\\ 0\\.002912874911912651\ \(0\)\
\-\ right\\:\\ 0\\.0028487573747564506\ \(0\)\
\-\ female\\:\\ 0\\.0027752926879112696\ \(0\)\
\-\ presents\\:\\ 0\\.002757731904435902\ \(0\)\
\-\ no\\:\\ 0\\.002718622909016752\ \(0\)\
\-\ images\\:\\ 0\\.0025896743948646984\ \(0\)\
\-\ \\.\\:\\ 0\\.0016263610534329256\ \(0\)\
\-\ year\\:\\ 0\\.0015104348645701654\ \(0\)\
\-\ old\\:\\ 0\\.0013822031546007181\ \(0\)\
\-\ with\\:\\ 0\\.0012938850436480698\ \(0\)\
\-\ \\(\\:\\ 0\\.001141171763418421\ \(0\)\
\-\ \\)\\:\\ 0\\.0011272317410952687\ \(0\)\
